Predictive Molecular Markers: Has the Time Come for Routine Use in Lung Cancer?

Author： Davies Angela M.   Mack Philip C.   Lara Primo N.   Lau Derick H.   Danenberg Kathleen   Gumerlock Paul H.   Gandara David R.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.2, Iss.2, 2004-03, pp. : 125-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pitfalls in Lung Cancer Molecular Pathology: How to Limit them in Routine Practice?

By  

Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. : 2638-2651

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer

By  

Current Medicinal Chemistry, Vol. 19, Iss. 22, 2012-08 ,pp. : 3689-3700

Bentham Science Publishers

Access to resources Recommend Favorite

Individual bioequivalence-has its time come?

By Endrenyi L.   Midha K.K.  

European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 4, 1998-10 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

Pharmacogenetics: Has the Time Come for Pharmacists to Embrace and Implement the Science?

By Beier Manju   Panchapagesan Madhumitha   Carman Ladd  

The Consultant Pharmacist, Vol. 28, Iss. 11, 2013-11 ,pp. : 696-711

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Integrating Pharmacogenetics for Assessment of Herb-Drug Interactions: Has the Time Come?

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 3, 2012-09 ,pp. : 247-253

Bentham Science Publishers

Access to resources Recommend Favorite